LegalNov 12, 2026, 08:01 AM
Skye Bioscience Wins Whistleblower Lawsuit Unanimously
AI Summary
Skye Bioscience, Inc. announced a significant legal victory as a jury returned a unanimous verdict in its favor on all claims in a whistleblower retaliation lawsuit filed by a former employee. The lawsuit, Wendy Cunning vs Skye Bioscience, Inc., alleged violations of whistleblower protections and retaliation under California law. The company anticipates the District Court will enter a judgment accordingly, though the plaintiff retains the option to file post-trial motions or appeal. Separately, the filing also provided an update on the proposed acquisition of Redx Pharma Limited, urging stockholders to read the preliminary proxy statement and other relevant SEC filings.
Key Highlights
- Skye Bioscience, Inc. won a unanimous jury verdict in a whistleblower retaliation lawsuit.
- The lawsuit, Wendy Cunning vs Skye Bioscience, Inc., alleged violation of whistleblower protections and retaliation.
- The jury found in favor of Skye Bioscience on all claims following a retrial.
- The company expects a judgment to be entered by the District Court in due course.
- The plaintiff may file post-trial motions or appeal the judgment.
Price Impact
More from SKYE